nach oben

ADHD Attention Deficit and Hyperactivity Disorders

Erschienen in:

11.08.2016 | Original Article

The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD

verfasst von: Jessica Morash-Conway, Melissa Gendron, Penny Corkum

Erschienen in: ADHD Attention Deficit and Hyperactivity Disorders | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The current study examined: (1) whether long-acting stimulant medication is effective in improving performance on measures of memory, attention, and academic productivity; and (2) whether sleep impacts the relationship between medication and performance. Participants were 21 newly diagnosed, medication-naïve children (mean age = 9.1 years) with ADHD, who participated in a 4-week blinded placebo-controlled randomized trial of long-acting MPH. Participants underwent assessments of sleep (i.e., polysomnography) and of cognitive performance. Long-acting stimulant medication was found to be an effective treatment for enhancing alerting attention, executive attention, working memory, and academic productivity, but resulted in poorer sleep. Moreover, sleep duration was found to impact the treatment response to medication, in that longer sleep duration at baseline was related to improved executive attention. These results underscore the importance of evaluating and monitoring sleep when prescribing stimulant medication as a treatment for ADHD in children.

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4 TR edn. American Psychiatric Association, Washington, DC

American Psychiatric Association (2014) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington, DC

Baddeley A (2012) Working memory: theories, models, and controversies. Annu Rev Psychol 63:1–29CrossRefPubMed

Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121(1):65–94. doi:10.1037/0033-2909.121.1.65 CrossRefPubMed

Barkley RA (2006) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment, 3rd edn. Guilford Press, New York

Bedard AC, Tannock R (2008) Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord 11(5):546–557CrossRefPubMed

Bonnet MH, Balkin TJ, Dinges DF, Roehrs T, Rogers NL, Wesensten NJ (2005) The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and stimulant task force of the American Academy of Sleep Medicine. Sleep 28(9):1163–1187PubMed

Callejas A, Lupianez J, Jesus-Funes M (2005) Modulations among the alerting, orienting and executive control networks. Exp Brain Res 167:27–37CrossRefPubMed

Charach A, Volpe T, Boydell KM, Gearing RE (2008) A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry 16:126–135CrossRefPubMed

Chaytor N, Schmitter-Edgecombe M (2003) The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol Rev 13(4):181–196CrossRefPubMed

Corkum P, Panton R, Ironside S, MacPherson M, Williams T (2008) Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol 33(4):368–379CrossRefPubMed

Corkum P, McGonnell M, Schachar R (2010) Factors affecting academic achievement in children with ADHD. J Appl Res Learn 3(9):1–14

Corkum P, Davidson F, MacPherson M (2011) A framework for the assessment and treatment of sleep problems in children with attention-deficit/hyperactivity disorder. Pediatr Clin North Am 58(3):667–683CrossRefPubMed

Davidson F, Cherry K, Corkum P (2015) Validating the behavior rating inventory of executive functioning for children with ADHD and their typically developing peers. Appl Neuropsychol Child. doi:10.1080/21622965.2015.1021957 PubMed

Fan J, McCandliss B, Sommer T, Raz A, Posner MI (2002) Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14(3):340–347CrossRefPubMed

Faraone SV, Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754–763CrossRefPubMed

Gruber R, Grizenko N, Schwartz G, Bellingham J, Guzman R, Joober R (2007) Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep Pediatric ADHD 30(8):1003–1009

Gruber R, Wiebe S, Montecalvo L, Brunetti B, Amsel R, Carrier J (2011) Impact of sleep restriction on neurobehavioral functioning of children with attention deficit hyperactivity disorder. Sleep 34(3):315–323PubMedPubMedCentral

Ironside S, Davidson F, Corkum P (2010) Circadian motor activity affected by stimulant medication in children with ADHD. J Sleep Res 9:546–551CrossRef

Ishigami Y, Klein RM (2010) Repeated measurement of the components of attention using two versions of the attention network task (ANT): stability, isolability, robustness, and reliability. J Neurosci Methods 190(1):117–128CrossRefPubMed

Konrad K, Gunther T, Hanish C, Herpertz-Dahlmann B (2004) Differential effects of methylphenidate on attentional function in children with ADHD. J Am Acad Child Adolesc Psychiatry 43:191–198CrossRefPubMed

Loe IM, Feldman HM (2007) Academic and educational outcomes of children with ADHD. J Pediatr Psychol 32(6):643–654CrossRefPubMed

Martinussen R, Hayden J, Hogg-Johnson S, Tannock R (2005) A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44(4):377–384CrossRefPubMed

McGonnell M, Corkum P, McKinnon M, MacPherson M, Williams T, Davidson C, Stephenson D (2009) Doing it right: an interdisciplinary model for the diagnosis of ADHD. J Can Acad Child Adoles Psychiatry 18(4):283–286

Mehta M, Goodyer I, Sahakian B (2004) Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45:293–305CrossRefPubMed

Mick E, Biederman J, Jetton J, Faraone SV (2000) Sleep disturbances associated with attention deficit hyperactivity disorder: the impact of psychiatric comorbidity and pharmacotherapy. J Child Adolesc Psychopharmacol 10(3):223–231CrossRefPubMed

Mullane JC, Corkum PV, Klein RM, McLaughlin EN, Lawrence MA (2011) Alerting, orienting, and executive attention in children with ADHD. J Atten Disord 15(4):310–320CrossRefPubMed

Muto V, Shaffii-LE Bourdiec A, Matarazzo L, Foret A, Macetti L, Jaspar M, Vandewalle G, Phillips C, Degueldre C, Balteau E, Luxen A, Collette F, Maquet P (2012) Influence of acute sleep loss on the neural correlates of alerting, orienting and executive attention components. J Sleep Res 21(6):648–658CrossRefPubMed

Oberlin BG, Alford JL, Marrocco RT (2005) Normal attention orienting but abnormal stimulus alerting and conflict in combined subtype of ADHD. Behav Brain Res 165:1–11CrossRefPubMed

Olson K, Jacobson KK, Van Oot P (2013) Ecological validity of pediatric neuropsychological measures: current state and future directions. Appl Neuropsychol 2(1):17–23CrossRef

Owens JA (2009) A clinical overview of seep and attention-deficit/hyperactivity disorder in children and adolescents. J Can Acad Child Adoles Psychiatry 18(2):92–102

Owens J, Gruber R, Brown T, Corkum P, Cortese S, O’Brien L, Stein M, Weiss M (2012) Future research directions in sleep and attention deficit hyperactivity disorder: report of a consensus working group. J Atten Disord 17(7):550–564CrossRefPubMed

Raggi VL, Chronis AM (2006) Interventions to address the academic impairment of children and adolescents with ADHD. Clin Child Fam Psychol Rev 9(2):85–111CrossRefPubMed

Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in health individuals: a systematic review. Pharmacol Res 62:187–206CrossRefPubMed

Sadeh A (2007) Consequences of sleep loss or sleep disruption in children. Sleep Med Clin 2:513–520CrossRef

Speth T, Benoit A, Corkum P (2015) Sleep parameters and architecture in children with attention-deficit/hyperactivity disorder: a comparison with typically developing peers and across subtypes. J Sleep Disord Treat Care 4:1

Steenari MM, Vuontela V, Paavonen J, Carlson S, Fjallberg M, Aronen ET (2003) Working memory and sleep in 6- to 13-year-old school children. J Am Acad Child Adoles Psychiatry 42(1):85–92CrossRef

Stein MA, Sarampote CS, Waldman IP, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH (2003) A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 115(5):404–413CrossRef

Swanson JM, Volkow ND (2009) Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 50:180–193CrossRefPubMedPubMedCentral

Swanson JM, Baler RD, Volkow ND (2011) Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology 36:207–226CrossRefPubMed

Vriend JL, Davidson FD, Corkum PV, McLaughlin EN, Chambers CT (2012) Sleep quantity and quality in relation to daytime functioning in children. Children’s Health Care 41(3):204–222CrossRef

Vriend JL, Davidson FD, Corkum PV, Rusak B, Chambers CT, McLaughlin EN (2013) Manipulating sleep duration alters emotional functioning and cognitive performance in children. J Pediatr Psychol 38(10):1058–1069CrossRefPubMed

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL (2011) Academic, behavioural, and cognitive effects of OROS^® methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21(2):121–131CrossRefPubMedPubMedCentral

Wigal SB, Greenhill LL, Nordbrock E, Connor DF, Kollins SH, Adjei A, Ann Childress, Stehli A, Kupper RJ (2014) A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 24(10):562–569CrossRefPubMedPubMedCentral

Wolraich ML, McGuinn L, Doffing M (2007) Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Saf 30:17–26CrossRefPubMed

Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S (2011) ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128:1007–1022CrossRefPubMed

Titel: The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD
verfasst von: Jessica Morash-Conway
Melissa Gendron
Penny Corkum
Publikationsdatum: 11.08.2016
Verlag: Springer Vienna
Erschienen in: ADHD Attention Deficit and Hyperactivity Disorders / Ausgabe 1/2017
Print ISSN: 1866-6116
Elektronische ISSN: 1866-6647
DOI: https://doi.org/10.1007/s12402-016-0204-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?

Acknowledgement to reviewers 2016

The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys

Is there a difference between child self-ratings and parent proxy-ratings of the quality of life of children with a diagnosis of attention-deficit hyperactivity disorder (ADHD)? A systematic review of the literature

Attention, reward, and inhibition: symptomatic features of ADHD and issues for offenders in the criminal justice system

Do Adult Attention Deficit Hyperactivity Disorder Quality-Of-Life (AAQoL) scale and the SF-36 scale measure the same construct of health-related quality of life?

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie